COLOPLASTCOLOPLASTCOLOPLAST

COLOPLAST

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪25.61 B‬CHF
2.85CHF
‪638.90 M‬CHF
‪3.42 B‬CHF
‪142.06 M‬
Beta (1Y)
0.50
Employees (FY)
‪16.64 K‬
Change (1Y)
+947 +6.03%
Revenue / Employee (1Y)
‪242.43 K‬CHF
Net income / Employee (1Y)
‪45.31 K‬CHF

About COLOPLAST B A/S


CEO
Kristian Villumsen
Headquarters
Humlebaek
Founded
1957
ISIN
DK0060448595
FIGI
BBG006TLNVX8
Coloplast A/S engages in the developing, manufacture, and markets medical products. It operates through the following segments: Chronic Care, Voice and Respiratory Care, Interventional Urology, Advanced Wound Dressings, and Biologics. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Voice and Respiratory Care segment refers to the sale of laryngectomy and tracheostomy products. The Interventional Urology segment includes the sale of urological products, including disposable products. The Advanced Wound Dressings segment focuses on the sale of wound and skin care products. The Biologics segment represents a new segment covering the sale of tissue-based products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
C
XS248128852
COLOPL. FIN. 22/30 MTN
Yield to maturity
3.19%
Maturity date
May 19, 2030
C
XS248128780
COLOPL. FIN. 22/27 MTN
Yield to maturity
2.80%
Maturity date
May 19, 2027

Explore more bonds 

Frequently Asked Questions


The current price of COLOB is 109.85 CHF — it hasn't changed in the past 24 hours. Watch COLOPLAST stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange COLOPLAST stocks are traded under the ticker COLOB.
We've gathered analysts' opinions on COLOPLAST future price: according to them, COLOB price has a max estimate of 129.35 CHF and a min estimate of 87.91 CHF. Watch COLOB chart and read a more detailed COLOPLAST stock forecast: see what analysts think of COLOPLAST and suggest that you do with its stocks.
COLOB reached its all-time high on Jul 30, 2018 with the price of 111.00 CHF, and its all-time low was 61.40 CHF and was reached on Jun 25, 2015. View more price dynamics on COLOB chart.
See other stocks reaching their highest and lowest prices.
COLOB stock is 0.00% volatile and has beta coefficient of 0.50. Track COLOPLAST stock price on the chart and check out the list of the most volatile stocks — is COLOPLAST there?
Today COLOPLAST has the market capitalization of ‪24.87 B‬, it has decreased by −1.71% over the last week.
Yes, you can track COLOPLAST financials in yearly and quarterly reports right on TradingView.
COLOPLAST is going to release the next earnings report on Feb 4, 2025. Keep track of upcoming events with our Earnings Calendar.
COLOB earnings for the last quarter are 0.69 CHF per share, whereas the estimation was 0.73 CHF resulting in a −5.06% surprise. The estimated earnings for the next quarter are 0.75 CHF per share. See more details about COLOPLAST earnings.
COLOPLAST revenue for the last quarter amounts to ‪879.31 M‬ CHF, despite the estimated figure of ‪869.82 M‬ CHF. In the next quarter, revenue is expected to reach ‪884.07 M‬ CHF.
COLOB net income for the last quarter is ‪166.17 M‬ CHF, while the quarter before that showed ‪164.13 M‬ CHF of net income which accounts for 1.24% change. Track more COLOPLAST financial stats to get the full picture.
As of Nov 14, 2024, the company has ‪16.64 K‬ employees. See our rating of the largest employees — is COLOPLAST on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COLOPLAST EBITDA is ‪1.10 B‬ CHF, and current EBITDA margin is 32.19%. See more stats in COLOPLAST financial statements.
Like other stocks, COLOB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COLOPLAST stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COLOPLAST technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COLOPLAST stock shows the buy signal. See more of COLOPLAST technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.